Title

Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy.

Document Type

Journal Article

Publication Date

2-1-2016

Journal

Arteriosclerosis, Thrombosis and Vascular Biology

Volume

36

Issue

2

Inclusive Pages

418-424

DOI

10.1161/ATVBAHA.115.306905

Keywords

Activated Protein C Resistance--complications; Coronary Disease--chemically induced; Estrogen Replacement Therapy--adverse effects; Estrogens--adverse effects; Lipoproteins--adverse effects; Progestins--adverse effects

Peer Reviewed

1